154 related articles for article (PubMed ID: 23369098)
1. Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study.
Skubisz M; Dutton P; Duncan WC; Horne AW; Tong S
BMC Pregnancy Childbirth; 2013 Feb; 13():30. PubMed ID: 23369098
[TBL] [Abstract][Full Text] [Related]
2. Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies.
Girija S; Manjunath AP; Salahudin A; Jeyaseelan L; Gowri V; Abu-Heija A; Al Kharusi L
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():230-233. PubMed ID: 28683376
[TBL] [Abstract][Full Text] [Related]
3. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
5. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy.
Kirk E; Condous G; Van Calster B; Haider Z; Van Huffel S; Timmerman D; Bourne T
Hum Reprod; 2007 Mar; 22(3):858-63. PubMed ID: 17088266
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
7. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
8. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.
Saraj AJ; Wilcox JG; Najmabadi S; Stein SM; Johnson MB; Paulson RJ
Obstet Gynecol; 1998 Dec; 92(6):989-94. PubMed ID: 9840564
[TBL] [Abstract][Full Text] [Related]
9. Day 1 change in maternal serum β-HCG levels as an early predictor of successful medical therapy in ectopic pregnancies.
Ahmed MR; Sayed Ahmed WA; Mohamed TY
J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2403-2407. PubMed ID: 30608010
[No Abstract] [Full Text] [Related]
10. Decline in βhCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study.
Skubisz MM; Li J; Wallace EM; Tong S
BJOG; 2011 Dec; 118(13):1665-8. PubMed ID: 21895960
[TBL] [Abstract][Full Text] [Related]
11. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy.
Agostini A; Blanc K; Ronda I; Romain F; Capelle M; Blanc B
Fertil Steril; 2007 Aug; 88(2):504-6. PubMed ID: 17418833
[TBL] [Abstract][Full Text] [Related]
13. The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success.
Cohen A; Almog B; Cohen Y; Bibi G; Rimon E; Levin I
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():103-107. PubMed ID: 28214759
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG.
Levin G; Dior U; Shushan A; Gilad R; Benshushan A; Rottenstreich A
Reprod Biomed Online; 2019 Jul; 39(1):149-154. PubMed ID: 31029556
[TBL] [Abstract][Full Text] [Related]
15. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.
Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ
Hum Reprod; 2016 Feb; 31(2):332-8. PubMed ID: 26701971
[TBL] [Abstract][Full Text] [Related]
16. Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.
Dai Y; Zhang G; Zhu L; Lang J; Liu Z
J Minim Invasive Gynecol; 2017; 24(7):1195-1199. PubMed ID: 28800968
[TBL] [Abstract][Full Text] [Related]
17. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy.
Natale A; Candiani M; Barbieri M; Calia C; Odorizzi MP; Busacca M
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):87-92. PubMed ID: 15474251
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the parameters in predicting single-dose methotrexate therapy success for ectopic pregnancy.
Deniz S; Ali B; Canan U; Yılmaz AH; Olcay I; Burcu D; Fatma GK
J Obstet Gynaecol Res; 2024 May; 50(5):856-863. PubMed ID: 38476034
[TBL] [Abstract][Full Text] [Related]
20. Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.
Wu J; Ludlow JP; De Vries B; Black K; Beale P
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):469-74. PubMed ID: 25287564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
